Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model
- PMID: 38384675
- PMCID: PMC10879803
- DOI: 10.1016/j.jobcr.2024.02.001
Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model
Abstract
Background: Tobacco is one of the main etiological factors for oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD). CYP1B1 is an enzyme which plays a major role in the phase I detoxification of tobacco, the byproducts of which are subsequently detoxified by phase II enzymes Glutathione S Transferase (GST). We attempted to evaluate the L432V polymorphism and tissue expression of CYP1B1, along with the oxidant-antioxidant status in OSCC progression model.
Method: ology: Tissue biopsies and blood samples were collected from the subjects; L432V polymorphism was evaluated by TaqMan RT-PCR, immunohistochemistry was performed on the tissue sample using CYP1B1 polyclonal primary antibody and Allred quick scoring system was used to evaluate the stained slides. Malonaldehyde (MDA) and GST activity were measured spectrophotometrically to assess oxidative-antioxidative status.
Results: When the L432V polymorphism was analyzed, it was observed that in oral epithelial dysplasia (OED) and OSCC, CG was more common than GG genotype. Highest mean Allred score was observed in tobacco users (6.27), highest GST activity was seen in oral epithelial dysplasia (5.006 U/ml) and highest MDA activity was observed in OSCC (1553.94 nm/ml).
Conclusion: Tobacco users with CG and GG genotypes are at equal risk of developing oral epithelial dysplasia or OSCC and L432V polymorphism does not appear to increase the risk of malignant transformation in oral epithelial dysplasia. Moreover, tobacco users with GG genotype and tissue expression of CYP1B1 may be at a greater risk of oxidative damage.
Keywords: CYP1B1; Malonaldehyde; Oral epithelial dysplasia; Oral squamous cell carcinoma; Tobacco.
© 2024 The Authors.
Conflict of interest statement
All the authors associated with the present manuscript declared no potential conflict of interest concerning the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Evaluation of CYP1B1 Expression, Oxidative Stress and Phase 2 Detoxification Enzyme Status in Oral Squamous Cell Carcinoma Patients.J Clin Diagn Res. 2017 Mar;11(3):BC01-BC05. doi: 10.7860/JCDR/2017/22196.9324. Epub 2017 Mar 1. J Clin Diagn Res. 2017. PMID: 28511368 Free PMC article.
-
Evaluation of Genetic Polymorphisms in Glutathione S-Transferase Theta1, Glutathione S-Transferase Mu1, and Glutathione S-Transferase Mu3 in Oral Leukoplakia and Oral Squamous Cell Carcinoma with Deleterious Habits using Polymerase Chain Reaction.Int J Appl Basic Med Res. 2017 Jul-Sep;7(3):181-185. doi: 10.4103/ijabmr.IJABMR_58_16. Int J Appl Basic Med Res. 2017. PMID: 28904918 Free PMC article.
-
An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.Indian J Otolaryngol Head Neck Surg. 2019 Dec;71(4):435-441. doi: 10.1007/s12070-019-01597-y. Epub 2019 Jan 23. Indian J Otolaryngol Head Neck Surg. 2019. PMID: 31750100 Free PMC article.
-
Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.J Oral Pathol Med. 2020 Jan;49(1):1-8. doi: 10.1111/jop.12920. Epub 2019 Aug 3. J Oral Pathol Med. 2020. PMID: 31309636 Review.
-
Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.BMC Oral Health. 2023 Sep 12;23(1):659. doi: 10.1186/s12903-023-03316-0. BMC Oral Health. 2023. PMID: 37697274 Free PMC article.
Cited by
-
Exploring anticancer potential of betanin in DMBA-induced oral squamous cell carcinoma: an in silico and experimental study.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug;398(8):10477-10494. doi: 10.1007/s00210-025-03909-2. Epub 2025 Feb 26. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40009172
References
-
- Camisasca D.R., Silami M.A., Honorato J., Dias F.L., de Faria P.A., Lourenço Sde Q. Oral squamous cell carcinoma: clinicopathological features in Subjects with and without recurrence. ORL J Otorhinolaryngol Relat Spec. 2011;73(3):170–176. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials